The company’s stock is beaten down (down over 90% from the 2017 high) after the company lost the PARP inhibitor race to competition like AstraZeneca (AZN) and sales of its PARP inhibitor Rubraca did not meet analyst expectations.
Similarly, Who is the CEO of Clovis Oncology?
President/CEO/Co-Founder, Clovis Oncology Inc.
Should I invest in Clovis Oncology? There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should « buy » Clovis Oncology stock. View analyst ratings for Clovis Oncology or view top-rated stocks.
Thereof, Is Clovis Oncology a good company?
Clovis Oncology has an overall rating of 3.6 out of 5, based on over 35 reviews left anonymously by employees. 47% of employees would recommend working at Clovis Oncology to a friend and 35% have a positive outlook for the business. This rating has improved by 8% over the last 12 months.
When did Clovis Oncology go public?
In addition, the underwriters have a 30-day option to purchase up to an additional 1,500,000 shares of common stock from Clovis Oncology to cover over-allotments, if any. Shares of Clovis Oncology’s common stock will trade on the NASDAQ Global Select Market under the symbol « CLVS » beginning on November 16, 2011.
What is the short interest on Clvs?
Clovis Oncology currently has a short interest ratio of 6.0. Learn More on Clovis Oncology’s short interest ratio.
Who owns Clvs?
Top 10 Owners of Clovis Oncology Inc
| Stockholder | Stake | Shares owned |
|---|---|---|
| The Vanguard Group, Inc. | 6.90% | 9,820,571 |
| BlackRock Fund Advisors | 5.82% | 8,284,149 |
| Palo Alto Investors LP | 2.81% | 3,997,826 |
| Geode Capital Management LLC | 1.56% | 2,212,612 |
Is Clvs a shorted stock?
Short Shares Availability
This table shows the number of shares of US:CLVS available to be shorted at a leading prime brokerage. It is not the total number of shares available to short, nor is it the short interest.
How much is Clvs shorted?
Short Interest: CLVS (NASDAQ)
| Clovis Oncology Incorporated | $ 2.65 |
|---|---|
| CLVS (NASDAQ) | -0.14 |
Join TheMoney.co community and don’t forget to share this post !
